×
About 305 results

ALLMedicine™ Pituitary Macroadenomas Center

Research & Reviews  119 results

Radiomic Features on Multiparametric MRI for Preoperative Evaluation of Pituitary Macro...
https://doi.org/10.1002/jmri.27930
Journal of Magnetic Resonance Imaging : JMRI; Wan T, Wu C et. al.

Sep 23rd, 2021 - Preoperative assessment of the consistency of pituitary macroadenomas (PMA) might be needed for surgical planning. To investigate the diagnostic performance of radiomics models based on multiparametric magnetic resonance imaging (mpMRI) for preope...

Evaluation of the Gross Total Resection Rate of Suprasellar Pituitary Macroadenomas wit...
https://doi.org/10.1016/j.wneu.2021.09.049
World Neurosurgery; Xiao J, Chen P et. al.

Sep 22nd, 2021 - Improving the gross total resection (GTR) rate of suprasellar pituitary macroadenomas (SPMAs) using the pure endoscopic endonasal transsphenoidal approach (EETA) has been a long-standing focus of neurosurgeons. This study was aimed at evaluating t...

Pituitary Macroadenomas
http://emedicine.medscape.com/article/123223-overview

Aug 11th, 2021 - Practice Essentials The sellar region is a site of various types of tumors. Pituitary adenomas are the most common. They arise from epithelial pituitary cells and account for 10-15% of all intracranial tumors. Tumors exceeding 10 mm are defined as...

Endoscopic Endonasal Approach for Giant Pituitary Adenoma Occupying the Entire Third Ve...
https://doi.org/10.1016/j.wneu.2021.07.022
World Neurosurgery; Jamaluddin MA, Patel BK et. al.

Jul 23rd, 2021 - Pituitary macroadenomas occasionally disrupt the sellae diaphragma and extend directly to the third ventricle causing hydrocephalus. We present the results of a single-stage extended endoscopic approach for managing giant pituitary adenomas (GPAs)...

T2-weighted magnetic resonance imaging as a novel predictor of surgical remission in ne...
https://doi.org/10.1016/j.jocn.2021.05.058
Journal of Clinical Neuroscience : Official Journal of Th... Akkaya E, Akgun MY et. al.

Jul 20th, 2021 - Any preoperative diagnostic assessment that can predict the success of the operation in acromegaly will provide a positive impact on overall remission rates. The aim of this study is to reveal whether the signal intensity in T2-weighted Magnetic R...

see more →

Clinicaltrials.gov  2 results

Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
https://clinicaltrials.gov/ct2/show/NCT00929669

Nov 28th, 2017 - Gonadotroph adenomas are the most common pituitary macroadenomas. Currently no medical treatment as been found that decreases the size of these adenomas, so surgery is the only treatment. The reason to think that pasireotide might affect gonadotro...

Value of 25 mcg Cortrosyn Stimulation Test
https://clinicaltrials.gov/ct2/show/NCT01428336

Jul 25th, 2017 - The study consisted of two groups of adult patients 18 to 65 years of age. The first group (G1, n=10) included patients with hypothalamic/pituitary disease with at least one pituitary axis deficiency other than ACTH deficiency. The patients had th...

see more →

News  1 results

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_6

Sep 16th, 2020 - Answer 5/5 Which of the following is accurate regarding treatment of acromegaly? Your peers chose: Pharmacologic therapy is the first-line treatment for acromegaly 0% Radiation therapy is routinely indicated for most patients with acromegaly 0% Fo...

see more →